Goals are to evaluate the novel GSK-3 inhibitor 9-ING-41 in combination with a panel of chemotherapeutic drugs used clinically to treat recurrent glioblastoma.
|Effective start/end date||1/1/16 → 12/31/17|
- Northwestern Memorial Hospital (NMH Master #7/Exhibit B.8)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.